Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-03

FDA Approved: LINAGLIPTIN AND METFORMIN HYDROCHLORIDE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original application for a generic fixed-dose combination of linagliptin and metformin hydrochloride (Novadoz Pharmaceuticals LLC). The product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LINAGLIPTIN AND METFORMIN HYDROCHLORIDE (linagliptin and metformin hydrochloride)

Snippet

ORIG AP for LINAGLIPTIN AND METFORMIN HYDROCHLORIDE (LINAGLIPTIN AND METFORMIN HYDROCHLORIDE)